Ticker Details
ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date:	December 14, 2012
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$468.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.23 | 1.14%
Avg Daily Range (30 D):	$3.12 | 1.23%
Avg Daily Range (90 D):	$3.16 | 1.37%

Institutional Daily Volume
Avg Daily Volume:	6.1M
Avg Daily Volume (30 D):	3.87M
Avg Daily Volume (90 D):	4.56M

Trade Size
Avg Trade Size (Sh.):	100
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	65,881
Avg Institutional Trade:	$11.24M
Avg Institutional Trade (30 D):	$31.35M
Avg Institutional Trade (90 D):	$35.19M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	19

Market Closing Trades
Avg Closing Trade:	$97.57M
Avg Closing Trade (30 D):	$260.65M
Avg Closing Trade (90 D):	$312.79M
Avg Closing Volume:	800.5K

News

Aug 23, 2026 @ 12:30 PM 2 Dividend Stocks to Buy and Never Sell Source: Dave Kovaleski

Aug 20, 2026 @ 7:30 PM Vertex Pharmaceuticals' Rally Has a New Engine -- ... Source: Prosper Junior Bakiny

Aug 19, 2026 @ 11:15 AM Invesco Nasdaq Biotech vs. Invesco Pharma: How Do ... Source: Erin Kennedy

Aug 14, 2026 @ 7:26 PM AbbVie vs. Bristol-Myers Squibb: Which Healthcare ... Source: Sara Appino

Aug 13, 2026 @ 7:34 PM Simplify's PINK or iShares' IYH: Which Healthcare ... Source: Sara Appino

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$3.54	$2.04	$.39
Diluted EPS	$3.54	$2.03	$.39
Revenue	$64.39B	$16.99B	$15B
Gross Profit	$46.02B	$12.7B	$10.78B
Net Income / Loss	$6.32B	$3.62B	$697M
Operating Income / Loss	$16.87B	$6.43B	$3.99B
Cost of Revenue	$18.37B	$4.29B	$4.22B
Net Cash Flow	$102M	$-2822M	$4.16B
PE Ratio